In June 2023, RANZCP unveiled a clinical memorandum “Therapeutic Usage of copyright Substances”. The goal of the memo was to tell psychiatrists concerning the possible therapeutic use of copyright substances to assistance the treatment of mental illness. Unlike “psilocybin&rdquo